Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04030507 · ClinicalTrials.gov registry record · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
A NA study of Breast Cancer and Metastatic Breast Cancer, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 214
- Enrollment target
- 1
- Study location
NCT04030507: Recruiting NA study of Breast Cancer and Metastatic Breast Cancer, sponsored by Brigham and Women's Hospital.
NCT04030507 is a NA study of Breast Cancer and Metastatic Breast Cancer that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 214 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04030507, a NA study of Breast Cancer and Metastatic Breast Cancer, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is studying the usefulness of magnetic resonance imaging (MRI) to screen for brain metastases (spread of the breast cancer to the brain).
Primary Outcome
For patients with HR+/HER2- or HER2+ metastatic breast cancer
Conditions Studied
Interventions
- DEVICE MRI
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2019-07-26 |
| Est. Completion | 2028-02 |
| Phase | NA |
What NCT04030507 shows while recruiting
NCT04030507 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower).
The record links to 6 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT04030507 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04030507 about?
NCT04030507 is a clinical study titled "Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer". This research study is studying the usefulness of magnetic resonance imaging (MRI) to screen for brain metastases (spread of the breast cancer to the brain).
What is the current status of trial NCT04030507?
This trial is currently recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2019-07-26. Estimated completion is 2028-02.
What conditions does trial NCT04030507 study?
This clinical trial studies the following conditions: Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer, HER2-positive Breast Cancer, Inflammatory Breast Cancer.
What interventions are being tested in trial NCT04030507?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT04030507?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04030507 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04030507's enrollment target sits among peer trials
214 350th of 1224 higher than 875 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- NCT05483465 · 214 participants · Phase 4
The Effect of NAD Supplementation on Brain Vascular Health in Aging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI